Two Sigma Investments’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,401
Closed -$301K 3380
2024
Q1
$301K Sell
20,401
-1,433
-7% -$21.2K ﹤0.01% 2491
2023
Q4
$293K Buy
+21,834
New +$293K ﹤0.01% 2624
2023
Q1
Sell
-42,490
Closed -$487K 3291
2022
Q4
$487K Buy
42,490
+20,971
+97% +$240K ﹤0.01% 1979
2022
Q3
$81K Sell
21,519
-3,400
-14% -$12.8K ﹤0.01% 2211
2022
Q2
$148K Sell
24,919
-5,820
-19% -$34.6K ﹤0.01% 2150
2022
Q1
$194K Sell
30,739
-5,227
-15% -$33K ﹤0.01% 2303
2021
Q4
$141K Sell
35,966
-9,949
-22% -$39K ﹤0.01% 2348
2021
Q3
$222K Sell
45,915
-16,204
-26% -$78.3K ﹤0.01% 2284
2021
Q2
$397K Sell
62,119
-154,722
-71% -$989K ﹤0.01% 2044
2021
Q1
$1.36M Sell
216,841
-50,714
-19% -$319K ﹤0.01% 1459
2020
Q4
$1.84M Buy
+267,555
New +$1.84M 0.01% 1100
2020
Q1
Sell
-18,714
Closed -$59K 2662
2019
Q4
$59K Sell
18,714
-3,600
-16% -$11.4K ﹤0.01% 2083
2019
Q3
$100K Sell
22,314
-6,937
-24% -$31.1K ﹤0.01% 1827
2019
Q2
$139K Sell
29,251
-33,642
-53% -$160K ﹤0.01% 1906
2019
Q1
$344K Sell
62,893
-29,734
-32% -$163K ﹤0.01% 1786
2018
Q4
$281K Buy
92,627
+20,659
+29% +$62.7K ﹤0.01% 1766
2018
Q3
$302K Buy
+71,968
New +$302K ﹤0.01% 1748
2015
Q3
Sell
-5,896
Closed -$574K 2364
2015
Q2
$574K Sell
5,896
-42,422
-88% -$4.13M ﹤0.01% 1660
2015
Q1
$4.52M Sell
48,318
-2,447
-5% -$229K 0.02% 737
2014
Q4
$4.51M Buy
50,765
+32,475
+178% +$2.89M 0.03% 674
2014
Q3
$1.26M Buy
18,290
+9,479
+108% +$655K 0.01% 1001
2014
Q2
$505K Buy
+8,811
New +$505K ﹤0.01% 1603
2014
Q1
Sell
-2,405
Closed -$101K 2441
2013
Q4
$101K Buy
+2,405
New +$101K ﹤0.01% 2082